Biolife Solutions (BLFS) Total Current Liabilities (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Total Current Liabilities data on file, last reported at $18.3 million in Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $18.3 million, down 34.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.3 million (down 34.16% YoY), and the FY2025 annual result was $23.0 million, down 29.8% from the prior year.
• Total Current Liabilities slipped to $18.3 million in Q1 2026 per BLFS's latest filing, from $23.0 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $47.3 million in Q1 2023 and troughed at $18.3 million in Q1 2026.
• A 5-year average of $34.7 million and a median of $36.4 million in 2022 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2022 and 2026: Total Current Liabilities jumped 130.46% in 2022, then plunged 34.16% in 2026.
• A 5-year view of Total Current Liabilities shows it stood at $44.6 million in 2022, then retreated by 5.39% to $42.2 million in 2023, then slipped by 22.39% to $32.7 million in 2024, then retreated by 29.8% to $23.0 million in 2025, then decreased by 20.57% to $18.3 million in 2026.
• Business Quant data shows BLFS's Total Current Liabilities at $18.3 million in Q1 2026, $23.0 million in Q4 2025, and $27.1 million in Q3 2025.